Transport and Retinal Capture of Lutein and Zeaxanthin with Reference to Age-related Macular Degeneration

Survey of Ophthalmology

Volumn 53, Issue 1, 2008, Pages 68-81

  Loane, Edward ^a   Nolan, John M ^a   O'Donovan, Orla ^a   Bhosale, Prakash ^c   Bernstein, Paul S ^c   Beatty, Stephen ^a,b  

^a Ireland   (Ireland)

^b WATERFORD REGIONAL HOSPITAL   (Ireland)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

absorption; age related macular degeneration; apolipoprotein E; lipoproteins; lutein; macular pigment; transport; xanthophyll binding proteins; zeaxanthin

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BINDING PROTEIN; CAROTENOID; GLUTATHIONE TRANSFERASE P1; LIPOPROTEIN; UNCLASSIFIED DRUG; XANTHOPHYLL; XANTHOPHYLL BINDING PROTEIN; ZEAXANTHIN;

ARTICLE; BLINDNESS; BLUE LIGHT; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME ISOLATION; EYE PROTECTION; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA; RETINA MACULA AGE RELATED DEGENERATION;

ABSORPTION; BIOLOGICAL TRANSPORT; DIETARY SUPPLEMENTS; HUMANS; LUTEIN; MACULAR DEGENERATION; PROGNOSIS; RETINA; XANTHOPHYLLS;

EID: 38049095535     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.10.008     Document Type: Article

References (100)

1. Abalain J.H., Carre J.L., Leglise D., et al. Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels?. Clin Chim Acta 326 (2002) 97-104
2. Anderson D.H., Ozaki S., Nealon M., et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 131 (2001) 767-781
3. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175 (1991) 880-885
4. Baird P.N., Guida E., Chu D.T., et al. The e2 and e4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45 (2004) 1311-1315
5. Beatty S., Boulton M., Henson D., et al. Macular pigment and age related macular degeneration. Br J Ophthalmol 83 (1999) 867-877
6. Beatty S., Koh H.H., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45 (2000) 115-134
7. Beatty S., Koh H.H., Murray I.J., et al. Macular pigment optical density and the risk for age-related macular degeneration. Invest Ophthalmol Vis Sci 41 (2000) B285
8. Berendschot T.T.J.M., Goldbohm R.A., Klopping W.A.A., et al. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41 (2000) 3322-3326
9. Bernstein P.S., Balashov N.A., Tsong E.D., and Rando R.R. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 38 (1997) 167-175
10. Bernstein P.S., Khachik F., Carvalho L.S., et al. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 72 (2001) 215-223
11. Bhosale P., and Bernstein P.S. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim Biophys Acta 1740 (2005) 116-121
12. Bhosale P., Larson A.J., Southwick K., et al. Identification and characterization of a zeaxanthin binding protein purified from human macula. Invest Ophthalmol Vis Sci 45 (2004) U322-U322
13. Billsten H.H., Bhosale P., Yemelyanov A., et al. Photophysical properties of xanthophylls in carotenoproteins from human retinas. Photochem Photobiol 78 (2003) 138-145
14. Boerwinkle E., and Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42 (1988) 104-112
15. Boerwinkle E., Visvikis S., Welsh D., et al. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Hum Genet 27 (1987) 567-582
16. Bone R.A., Landrum J.T., Fernandez L., and Tarsis S.L. Analysis of the macular pigment by HPLC-Retinal distribution and age study. Invest Ophthalmol Vis Sci 29 (1988) 843-849
17. Bone R.A., Landrum J.T., Friedes L.M., et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64 (1997) 211-218
18. Boyles J.K., Zoellner C.D., Anderson L.J., et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83 (1989) 1015-1031
19. Chan C., Leung I., Lam K.W., and Tso M.O. The occurrence of retinol and carotenoids in human subretinal fluid. Curr Eye Res 17 (1998) 890-895
20. Clevidence B.A., and Bieri J.G. Association of carotenoids with human plasma lipoproteins. Methods Enzymol 214 (1993) 33-46
21. Congdon N., O'Colmain B., Klaver C.C., et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
22. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
23. Davignon J., Cohn J.S., Mabile L., and Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 286 (1999) 115-143
24. Dentchev T., Milam A.H., Lee V.M., et al. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 9 (2003) 184-190
25. During A., and Harrison E.H. Intestinal absorption and metabolism of carotenoids: insights from cell culture. Arch Biochem Biophys 430 (2004) 77-88
26. During A., Hussain M.M., Morel D.W., and Harrison E.H. Carotenoid uptake and secretion by CaCo-2 cells: beta-carotene isomer selectivity and carotenoid interactions. J Lipid Res 43 (2002) 1086-1095
27. Durrington P.N. Lipoproteins and their metabolism. In: Durrington P.N. (Ed). Hyperlipidaemia: Diagnosis and Management (1989), Butterworth-Heinemann Ltd
28. Ehnholm C., Mahley R.W., Chappell D.A., et al. Role of apolipoprotein E in the lipolytic conversion of b-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci USA 81 (1984) 5566-5570
29. Erdman Jr. J.W., Bierer T.L., and Gugger E.T. Absorption and transport of carotenoids. Ann NY Acad Sci 691 (1993) 76-85
30. Gale C.R., Hall N.F., Phillips D.I.W., and Martyn C.N. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 44 (2003) 2461-2465
31. Goldstein J.L., and Brown M.S. The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy. Med Clin North Am 66 (1982) 335-362
32. Gotoh N., Kuroiwa S., Kikuchi T., et al. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Am J Ophthalmol 138 (2004) 567-573
33. Goulinet S., and Chapman M.J. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols oxygenated and hydrocarbon carotenoids-Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol 17 (1997) 786-796
34. Gregg R.E., Zech L.A., Schaefer E.J., et al. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78 (1986) 815-821
35. Haegerstrom-Portnoy G. Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment?. J Opt Soc Am A 5 (1988) 2140-2144
36. Ham Jr. W.T., Mueller H.A., and Sliney D.H. Retinal sensitivity to damage from short wavelength light. Nature 260 (1976) 153-155
37. Hammond B.R., Johnson E.J., Russell R.M., et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38 (1997) 1795-1801
38. Hammond B.R., Wooten B.R., and Snodderly D.M. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 14 (1997) 1187-1196
39. Hayes K.C. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophthalmol 13 (1974) 499-510
40. Ishida B.Y., Bailey K.R., Duncan K.G., et al. Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res 45 (2004) 263-271
41. Johnson E.J., Hammond B.R., Yeum K.J., et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 71 (2000) 1555-1562
42. Johnson E.J., Neuringer M., Russell R.M., et al. Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 46 (2005) 692-702
43. Khachik F., Beecher G.R., and Goli M.B. Separation, identification and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromatography. Pure Appl Chem 63 (1991) 71-80
44. Khachik F., Bernstein P.S., and Garland D.L. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38 (1997) 1802-1811
45. Khachik F., de Moura F.F., Zhao D.Y., et al. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci 43 (2002) 3383-3392
46. Khachik F., Spangler C.J., Smith Jr. J.C., et al. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem 69 (1997) 1873-1881
47. Klaver C.C., Kliffen M., van Duijn C.M., et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63 (1998) 200-206
48. Koh H.H., Murray I.J., Nolan D., et al. Serum and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 79 (2004) 21-27
49. Kostic D., White W.S., and Olson J.A. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 62 (1995) 604-610
50. Krinsky N.I., and Deneke S.M. Interaction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst 69 (1982) 205-210
51. Kuhrt H., Hartig W., Grimm D., et al. Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J Hirnforsch 38 (1997) 223-229
52. Landrum J.T., Bone R.A., JOA HILD, et al. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 65 (1997) 57-62
53. Leon A.S., Togashi K., Rankinen T., et al. Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE family study. Metabolism 53 (2004) 108-116
54. Leung I.Y.F., Sandstrom M.M., Zucker C.L., et al. Nutritional manipulation of primate retinas, II: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest Ophthalmol Vis Sci 45 (2004) 3244-3256
55. Lim B.P., Nagao A., Terao J., et al. Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. Biochim Biophys Acta 1126 (1992) 178-184
56. Mahley R.W., and Innerarity T.L. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 737 (1983) 197-222
57. Mahley R.W., Innerarity T.L., Rall Jr. S.C., and Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 25 (1984) 1277-1294
58. Mouchel Y., Lefrancois T., Fages C., and Tardy M. Apolipoprotein E gene expression in astrocytes: developmental pattern and regulation. Neuroreport 7 (1995) 205-208
59. Neuringer M., Connor W.E., Lin D.S., et al. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 83 (1986) 4021-4025
60. Neuringer M., Sandstrom M.M., Johnson E.J., and Snodderly D.M. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci 45 (2004) 3234-3243
61. Nolan J., O'Donovan O., Kavanagh H., et al. Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 45 (2004) 3940-3950
62. Ong J.M., Zorapapel N.C., Rich K.A., et al. Effects of cholesterol and apolipoprotein E on retinal abnormalities in apoE-deficient mice. Invest Ophthalmol Vis Sci 42 (2001) 1891-1900
63. Oz O., Aras A.N., Tamer L., et al. Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Eur J Ophthalmol 16 (2006) 105-110
64. Pang C.P., Baum L., Chan W.M., et al. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 214 (2000) 289-291
65. Parra H.J., Arveiler D., Evans A.E., et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 12 (1992) 701-707
66. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17 (1994) 525-530
67. Quarmby B., Norden D.A., Zagalsky P.F., et al. Studies on the quaternary structure of the lobster exoskeleton carotenoprotein, crustacyanin. Comp Biochem Physiol B 56 (1977) 55-61
68. Reboul E., Abou L., Mikail C., et al. Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). Biochem J 387 (2005) 455-461
69. Richer S., Stiles W., Statkute L., et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75 (2004) 216-230
70. Rodriguez-Carmona M., Kvansakul J., Harlow J.A., et al. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Ophthalmic Physiol Opt 26 (2006) 137-147
71. Schmidt S., Haines J.L., Postel E.A., et al. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 11 (2005) 941-949
72. Schmidt S., Klaver C., Saunders A., et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23 (2002) 209-223
73. Schneeberger S.A., Iwahashi C.K., Hjelmeland L.M., et al. Apolipoprotein E in the subretinal fluid of rhegmatogenous and exudative retinal detachments. Retina 17 (1997) 38-43
74. Schneider W.J., Kovanen P.T., Brown M.S., et al. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 68 (1981) 1075-1085
75. Schultz D.W., Klein M.L., Humpert A., et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 121 (2003) 679-683
76. Seddon J.M., Cote J., Davis N., and Rosner B. Progression of age-related macular degeneration: associated with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121 (2003) 785-792
77. Shanmugaratnam J., Berg E., Kimerer L., et al. Retinal muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Brain Res Mol Brain Res 50 (1997) 113-120
78. Siems W.G., Sommerburg O., and van Kuijk F.J. Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors 10 (1999) 105-113
79. Simonelli F., Margaglione M., Testa F., et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res 33 (2001) 325-328
80. Snipes G.J., McGuire C.B., Norden J.J., and Freeman J.A. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA 83 (1986) 1130-1134
81. Snodderly D.M., Auran J.D., and Delori F.C. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25 (1984) 674-685
82. Snodderly D.M., Handelman G.J., and Adler A.J. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32 (1991) 268-279
83. Sommerburg O., Keunen J.E.E., Bird A.C., and van Kuijk F.J.G.M. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82 (1998) 907-910
84. Souied E.H., Benlian P., Amouyel P., et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125 (1998) 353-359
85. Stahl W., and Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 122 (1992) 2161-2166
86. Stewart J.E., Skinner E.R., and Best P.V. Receptor binding of an apolipoprotein E-rich subfraction of high density lipoprotein to rat and human brain membranes. Int J Biochem Cell Biol 30 (1998) 407-415
87. Sugawara T., Kushiro M., Zhang H., et al. Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. J Nutr 131 (2001) 2921-2927
88. Thomson L.R., Toyoda Y., Langner A., et al. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci 43 (2002) 3538-3549
89. Toyoda Y., Thomson L.R., Langner A., et al. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail. Invest Ophthalmol Vis Sci 43 (2002) 1210-1221
90. Utermann G., Langenbeck U., Beisiegel U., and Weber W. Genetics of the apolipoprotein E system in man. Am J Hum Genet 32 (1980) 339-347
91. Van den Berg H., and Van Vliet T. Effect of simultaneous, single oral doses of beta-carotene with lutein or lycopene on the beta-carotene and retinyl ester responses in the triacylglycerol-rich lipoprotein fraction of men. Am J Clin Nutr 68 (1998) 82-89
92. Viroonudomphol D., Pongpaew P., Tungtrongchitr R., et al. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr 12 (2003) 73-79
93. Weisgraber K.H., Innerarity T.L., and Mahley R.W. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257 (1982) 2518-2521
94. Werder M., Han C.H., Wehrli E., et al. Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine. Biochemistry 40 (2001) 11643-11650
95. Werner J.S., and Steele V.G. Sensitivity of human foveal color mechanisms throughout the life span. J Opt Soc Am A 5 (1988) 2122-2130
96. White W.S., Stacewicz-Sapuntzakis M., Erdman Jr. J.W., and Bowen P.E. Pharmacokinetics of beta-carotene and canthaxanthin after ingestion of individual and combined doses by human subjects. J Am Coll Nutr 13 (1994) 665-671
97. Yemelyanov A.Y., Katz N.B., and Bernstein P.S. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 72 (2001) 381-392
98. Yeum K.J., and Russell R.M. Carotenoid bioavailability and bioconversion. Annu Rev Nutr 22 (2002) 483-504
99. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122 (2004) 598-614
100. Zareparsi S., Reddick A.C., Branham K.E.H., et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 45 (2004) 1306-1310